SELL news

Latest 1 stories · newest Nov 20, 2026

SELL
SELLAS Life Sciences files Underwriting Agreement

SELLAS Life Sciences Group filed a prospectus to initially sell 11.5M shares of common stock, with underwriters J.P. Morgan and TD Securities, while also reserving options to sell up to 1.7M additional shares.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same SELL feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/SELL/newsSTART FREE